Zobrazeno 1 - 10
of 15
pro vyhledávání: '"E. I. Zhelnova"'
Autor:
T. S. Chudnova, E. A. Baryakh, M. S. Litvinenko, T. N. Tolstykh, O. L. Kochneva, E. Y. Grishina, E. N. Misyurina, K. V. Yatskov, E. I. Zhelnova, Y. Y. Polyakov, K. V. Kaluzhskaya
Publikováno v:
Онкогематология, Vol 17, Iss 2, Pp 107-120 (2022)
In the era of COVID-19, the chemotherapy of patients with hematological malignancies has become the cornerstone in hematology. Secondary immunodeficiency as a result of hemoblastosis, predisposes to a more severe course of coronavirus infection, and
Externí odkaz:
https://doaj.org/article/4193169dc7fd4d628f4896e9cce3fcb9
Autor:
N. G. Poteshkina, A. A. Troshina, M. Y. Maslova, M. A. Lysenko, I. V. Samsonova, E. I. Zhelnova
Publikováno v:
Медицинский совет, Vol 0, Iss 5, Pp 104-108 (2018)
Mediastinal masses include a wide range of both benign and malignant diseases. Current evidence shows that they constitute 3–7% of all oncological diseases, with primary tumours (thymoma, lymphoma, germ cell tumours) accounting for 3% of all medias
Externí odkaz:
https://doaj.org/article/556adf8443ab47cfaa4e67aed40b5e84
Publikováno v:
Онкогематология, Vol 8, Iss 3, Pp 55-59 (2014)
Most anemia cases associated with iron deficiency. There are various therapeutic approaches to compensate iron deficiency. In some cases,a rapid restore of body iron is required, which is only possible with intravenous administration. Now a number of
Externí odkaz:
https://doaj.org/article/8f45468393c541b2a522db0fb484e39b
Autor:
Ol'ga Olegovna Shchegolevataya, Elena Nikolaevna Parovichnikova, I A Demidova, Valentin Grigor'evich Isaev, Andrey Nikolaevich Sokolov, Evgeniya Ivanovna Zhelnova, I V Alekseeva, V A Zherebtsova, T V Gaponova, Elena Vasil'evna Domracheva, Andrey Vital'evich Misyurin, L P Poreshina, I B Kaplanskaya, Elena Nikolaevna Ustinova, Elena Olegovna Gribanova, Valeriy Grigor'evich Savchenko, O O Schegolevataya, E N Parovichnikova, V G Isaev, A N Sokolov, E I Zhelnova, E V Domracheva, A V Misyurin, E N Ustinova, E O Gribanova, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 83, Iss 3, Pp 57-62 (2011)
Development of leukemia from donor cells is a rare complication of allogeneic blood stem cells (BSC). The paper describes a case of evolving acute myeloid leukemia of a graft in a patient with resistant acute monoblastic leukemia after related alloge
Externí odkaz:
https://doaj.org/article/482819152341484fa8015636967cbd83
Autor:
O A Vinogradova, V G Savchenko, E V Domracheva, E N Parovichnikova, L V Dyachenko, G A Alimova, L P Mendeleeva, L S Lyubimova, A N Sokolov, E I Zhelnova, O S Pokrovskaya
Publikováno v:
Терапевтический архив, Vol 79, Iss 7, Pp 28-34 (2004)
Aim. To genotype tumor cells in the recurrence of leukemia after allogenic transplantation of bone marrow (TBM). Material and methods. Standard cytogenetics and fluorescent hybridization in situ (FISH) with a probe to the centrometic sites of X/Y chr
Externí odkaz:
https://doaj.org/article/e42f905f787640318a16c48f4cb3e5ee
Autor:
S V Semochkin, E. I. Zhelnova, N. A. Aref’eva, D. O. Sinyavkin, K. V. Yatskov, O. N. Kotenko, E.N. Misyurina, M.A. Lysenko, I. V. Samsonova, D. E. Gagloeva, E A Baryakh, T. N. Tolstykh, E. V. Yurova, A. I. Ushakova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 167:267-271
Prognostic value of N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) was analyzed in patients with multiple myeloma complicated by dialysisdependent renal failure. The prospective study included 20 patients with newly
Autor:
E. I. Zhelnova, S V Semochkin, N. A. Aref’eva, T. N. Tolstykh, D. E. Gagloeva, A. I. Ushakova, A.V. Cherkasova, E.N. Misyurina, M.A. Lysenko, I. V. Samsonova, D. O. Sinyavkin, K. V. Yatskov, O. N. Kotenko, E.A. Baryakh
Publikováno v:
Annals of Oncology. 30:v441
Background About 20-30% patients with newly diagnosed multiple myeloma (ND MM) experience damage to kidneys and in 2-4% of cases, hemodialysis is required. NT‐proBNP synthesize in atria and ventricles cardiomyocytes and excreted by the kidney. The
Autor:
S V Semochkin, E. Grishina, E. Karimova, T. N. Tolstykh, O. Kochneva, E. Mavrina, E.A. Baryakh, N. Arkhipova, E. I. Zhelnova, E. Yaskova, Y. Polyakov, E.N. Misyurina
Publikováno v:
Annals of Oncology. 29:viii368-viii369
Publikováno v:
Anesteziologiia i reanimatologiia. (5)
Infusion solutions are able to change the hemostatic system. Thromboelastography (TEG) is an integral technique to evaluate the hemostatic system. TEG was used to evaluate the effect of three infusion solutions (6% hydroxyexyethyl starch (HES) 200/0.
Autor:
E I, Zhelnova, L P, Mendeleeva, L S, Liubimova, I A, Demidova, E N, Parovichnikova, L P, Poreshina, R M, Kut'ina, A P, Shpakova, I B, Kaplanskaia, N N, Kalinin, V G, Savchenko
Publikováno v:
Terapevticheskii arkhiv. 79(8)